Tina Shah Selected Research

Tina Shah Research Topics

Disease

14	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2009
12	Coronary Disease (Coronary Heart Disease) 10/2021 - 02/2009
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 08/2008
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 11/2014
4	Heart Failure 01/2021 - 12/2009
4	Stroke (Strokes) 10/2020 - 12/2009
4	Hypertension (High Blood Pressure) 01/2018 - 12/2009
3	Insulin Resistance 01/2019 - 08/2008
3	Ischemic Stroke 06/2017 - 04/2013
3	Inflammation (Inflammations) 04/2013 - 08/2008
2	Heart Diseases (Heart Disease) 12/2023 - 06/2006
2	Hemorrhage 01/2022 - 12/2011
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018 - 06/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 06/2017 - 01/2017
2	Renal Insufficiency (Renal Failure) 01/2017 - 12/2009
1	Shock 12/2023
1	Cognitive Dysfunction 01/2023
1	ST Elevation Myocardial Infarction 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Obesity 01/2018
1	Atrial Fibrillation 01/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Infections 01/2018
1	Pain (Aches) 01/2018
1	Orbital Pseudotumor 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2017
1	Genetic Risk Score 10/2016
1	Diabetes Mellitus 04/2016
1	Body Weight (Weight, Body) 01/2015
1	Peripheral Arterial Disease 01/2015
1	Rheumatoid Arthritis 03/2012
1	Thrombosis (Thrombus) 12/2011
1	Hypertrophy 01/2010
1	Neoplasms (Cancer) 12/2009
1	Atherosclerosis 08/2008
1	Periodontitis 04/2005

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 10/2021 - 11/2009
8	C-Reactive ProteinIBA 09/2012 - 06/2006
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2015
4	Interleukin-6 (Interleukin 6)IBA 06/2017 - 04/2005
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016 - 01/2015
3	LDL CholesterolIBA 10/2020 - 01/2015
3	Insulin (Novolin)FDA Link 01/2020 - 01/2015
2	oxidized low density lipoproteinIBA 10/2020 - 04/2013
2	Lipoproteins (Lipoprotein)IBA 10/2020 - 01/2018
2	ApolipoproteinsIBA 01/2018 - 04/2013
2	Biomarkers (Surrogate Marker)IBA 04/2013 - 02/2012
1	KetonesIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	CalciumIBA 11/2019
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	Digoxin (Digitek)FDA LinkGeneric 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	SteroidsIBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	Cocaine (Cocaine HCl)IBA 01/2017
1	Uric Acid (Urate)IBA 04/2016
1	HDL CholesterolIBA 03/2015
1	Coenzyme A (CoA)IBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Oxidoreductases (Dehydrogenase)IBA 01/2015
1	CholesterolIBA 01/2015
1	Bronchodilator Agents (Bronchodilators)IBA 11/2014
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 07/2014
1	CytokinesIBA 04/2013
1	ORALIT (ORS)IBA 04/2013
1	Apolipoproteins E (ApoE)IBA 04/2013
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2012
1	Monoclonal AntibodiesIBA 03/2012
1	tocilizumab (atlizumab)FDA Link 03/2012
1	Cytochrome P-450 CYP2C19IBA 12/2011
1	Clopidogrel (Plavix)FDA Link 12/2011
1	EnzymesIBA 12/2011
1	Rosuvastatin Calcium (Crestor)FDA Link 10/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2009
1	Hemoglobins (Hemoglobin)IBA 08/2008

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2015
2	Secondary Prevention 01/2022 - 09/2017
2	Dry Powder Inhalers 01/2018 - 01/2018
2	Nebulizers and Vaporizers (Inhaler) 01/2018 - 01/2018
2	Metered Dose Inhalers (Metered Dose Inhaler) 01/2018 - 01/2018
2	Patient Readmission 10/2016 - 05/2015
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2023
1	Cardiac Rehabilitation 01/2021
1	Electric Countershock (Cardioversion) 01/2018
1	Length of Stay 01/2018
1	Respiratory Therapy (Therapy, Respiratory) 01/2018
1	Meditation 09/2017
1	Subacute Care 05/2015
1	Stents 12/2011
1	Drug Therapy (Chemotherapy) 12/2009